Standard Operating Procedure for Quality Control Testing of Transdermal Patches

1) Purpose

The purpose of this SOP is to establish a standardized procedure for the quality control testing of transdermal patches to ensure they meet the required specifications for safety, efficacy, and quality.

2) Scope

This SOP applies to all transdermal patches manufactured within the facility and intended for quality control testing, including but not limited to drug release rate, adhesion, thickness, and uniformity of dosage units.

3) Responsibilities

The Quality Control (QC) department is responsible for conducting and documenting all quality control tests on transdermal patches. The QC manager ensures compliance with this SOP and regulatory requirements.

4) Procedure

4.1 Preparation

• 4.1.1 Ensure all testing equipment is calibrated and in proper working condition.
• 4.1.2 Verify the availability of necessary reagents, standards, and reference materials.
• 4.1.3 Review the batch manufacturing record and sampling plan for the batch to be tested.

4.2 Sampling

• 4.2.1 Collect samples according to the approved sampling plan.
• 4.2.2 Label the samples appropriately and record the details in the sample logbook.

4.3 Testing Procedures

• 4.3.1 Drug Release Rate Testing:
  • 4.3.1.1 Prepare the dissolution medium as specified in the method.
  • 4.3.1.2 Place the transdermal patch in the dissolution apparatus.
  • 4.3.1.3 Collect samples at specified intervals and analyze using HPLC.
  • 4.3.1.4 Calculate